Injective now has a US staked ETF on Nasdaq, a new supply-cut vote that passed with over 99% support, and a big upgrade on the way. Yet INJ trades near $7, about 87% below its high, with extreme fear in the market. Here's the full picture
WHAT IT IS
Injective is a finance-focused blockchain. It's built for onchain trading, derivatives and tokenized real-world assets like stocks, commodities and money-market funds. INJ pays fees, secures the chain through staking, and takes part in governance.
WHERE IT CAME FROM
Launched in 2020 and grew through DeFi's boom. The all-time high is $52.75 (Mar 14, 2024). Native EVM support went live on Nov 11, 2025, so Ethereum-style apps can run on it. Canary Capital's staked INJ ETF (ticker INJC) started trading on Nasdaq on Nov 5. Two other INJ ETFs are pending: 21Shares and REX-Osprey.
TOKENOMICS
• Max supply: 100M INJ. About 100M is already circulating.
• Market cap: about $700M
• Governance passed "Supply Squeeze" (IIP-617) with 99.89% support. It lowers new issuance and keeps the buyback-and-burn program.
• Burned so far: about 6.85M-7.1M INJ, depending on the source
• Holders can commit INJ to monthly buybacks. The tokens are burned and participants share protocol revenue.
THE PRICE STORY
• High: $52.75. Now about 87% below it.
• Now: about $7.00, with a 24h range of $6.85-$7.46
• Down about 7% in 7 days (one source)
• Nov 14-15: dropped about 11% in one day, from a $8.25 high to a $6.56 low
• INJ was up over 5% on the ETF launch day (Nov 5), then gave it back
• Futures open interest: about $127M. Funding is slightly negative.
• Fear & Greed: 11, extreme fear (Nov 15)
THE LEVELS
• Support: $6.56 (key floor), $6.30 (200-day average), then $5.18
• Resistance: $6.94 (neckline, now being tested), $7.53, $7.68, then $8.22 and $9.41
3 SCENARIOS
Bull: price reclaims $7.68 on higher volume, and heads to $8.22, then $9.41.
Base: it ranges between $6.56 and $7.68 while the market stays fearful.
Bear: $6.56 breaks on a daily close, and price slides to $6.30, then $5.18.
TRADE IDEA (analysis, not advice)
Entry zone: $6.70-$7.00 (example: $6.85)
Stop: daily close below $6.30
Targets: $7.68, then $8.22
Risk/reward: about 1.5:1 to the first target, 2.5:1 to the second
This is a support-bounce idea. A chart reader sees a head-and-shoulders break, so the trend is still weak. Use small size.
RISKS
• The ETF launch added little visible buying
• Spot volume is thin (about $21M a day)
• Revenue is still small (about $3.4M over 12 months as of June, per CoinGecko)
• The whole market is in fear, with a possible rate hike ahead
• Token burns work only if protocol revenue grows
MY TAKE
Injective has real products, a clear burn plan and now an ETF. But good news hasn't stopped the slide, so the market wants proof of revenue. I'd rather buy support with a stop than chase a bounce.
Do you buy the dip or wait for $7.68?
Not financial advice. DYOR
#inj $INJ